Osamagbe Woghiren | Senior Manager, QPPV Office & International Pharmacovigilance Operations
UCB

BioTechX USA Day 2 @ 12:25

Maximizing the Value of Real-World Evidence for Patient Safety

As the pharmaceutical industry becomes increasingly data-driven, organizations are generating more real-world data (RWD) and real-world evidence (RWE) than ever before. While RWE presents significant opportunities to enhance patient safety, realizing its full value requires navigating operational, methodological, and regulatory complexities.

Realizing this value requires strong collaboration between patient safety and RWE functions to ensure evidence is appropriately contextualized and translated into meaningful action.

Drawing on practical examples and lessons learned, this session explores the opportunities and challenges at the intersection of patient safety and RWE.

Attendees will gain insights into approaches for strengthening cross-functional collaboration, leveraging RWE more effectively, and improving confidence in the safe use of medicines.

Osamagbe Woghiren, Senior Manager, QPPV Office & International Pharmacovigilance Operations, UCB

×

Osamagbe Woghiren / Maximizing the Value of Real-World Evidence for Patient Safety

Osamagbe Woghiren, Senior Manager, QPPV Office & International Pharmacovigilance Operations,
UCB

Dr. Osamagbe (Osa) Woghiren, PharmD works at the intersection of QPPV governance, global pharmacovigilance systems, and international safety operations. Her experience spans U.S., EU/EEA, and UK pharmacovigilance environments, giving her a cross-jurisdictional perspective that is increasingly...

CloseMore